Image Viewer

Pfizer is advancing its research in cancer treatment with a focus on bi-specific antibodies and antibody-drug conjugates (ADCs). The company is part of the BBC StoryWorks “Rewriting Cancer” series, highlighting its innovative approach. At Europe's biggest oncology conference, #ESMO24, on September 17, Pfizer's data presentations have positioned the company as a leader in treating a common cancer condition with no approved treatments in the US or Europe.